Literature DB >> 19629210

Regional differences in the prevalence of the metabolic syndrome in primary care practices in Germany.

Susanne Moebus, Jens Hanisch, Peter Bramlage, Christian Lösch, Hans Hauner, Jürgen Wasem, Karl-Heinz Jöckel.   

Abstract

INTRODUCTION: Data on the prevalence and regional distribution of the metabolic syndrome in Germany are lacking, in particular for primary care.
METHODS: In October 2005 anthropometric measurements were taken from 35 869 consecutive patients aged 18 to 99 years, in 1511 primary care practices. Waist circumference, blood pressure, lifestyle, and past medical history were assessed and blood tests taken (HDL-, LDL- and total cholesterol, triglycerides, glucose). Crude and age-standardized prevalence were calculated.
RESULTS: Women in the eastern part of Germany showed a higher age-standardized prevalence of the metabolic syndrome than women in the western part (21.1%; 95% CI: 19.9 to 22.4 respectively 17.7%; 95% CI: 17.2 to 18.3). In men the prevalences were 22.7% (95% CI: 20.9 to 24.4) and 21.4% (95% CI: 20.6 to 22.1) respectively. Patients from Saxony-Anhalt, Brandenburg, and Mecklenburg-Western Pomerania showed the highest prevalence, while women in Hamburg, Berlin, and Hesse and men in Schleswig-Holstein, Saarland, and Hamburg showed the lowest prevalence. Cardiovascular disease prevalence was comparable, while diabetes prevalence was higher in patients from eastern Germany (17% vs.13% in men; 12% vs. 9% in women). DISCUSSION: The prevalence of the metabolic syndrome in German primary care is high. Prevention efforts should focus in particular on differences in gender, socioeconomic status, and region.

Entities:  

Keywords:  Germany; cardiovascular risk factors; diabetes mellitus; metabolic syndrome; prevalence; primary care

Year:  2008        PMID: 19629210      PMCID: PMC2696781          DOI: 10.3238/artzebl.2008.0207

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  20 in total

Review 1.  Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Circulation       Date:  2004-01-27       Impact factor: 29.690

2.  Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle.

Authors:  Axel Schmermund; Stefan Möhlenkamp; Andreas Stang; Dietrich Grönemeyer; Rainer Seibel; Herbert Hirche; Klaus Mann; Winfried Siffert; Karl Lauterbach; Johannes Siegrist; Karl-Heinz Jöckel; Raimund Erbel
Journal:  Am Heart J       Date:  2002-08       Impact factor: 4.749

3.  The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe.

Authors:  S Sans; H Kesteloot; D Kromhout
Journal:  Eur Heart J       Date:  1997-08       Impact factor: 29.983

4.  Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design.

Authors:  U John; B Greiner; E Hensel; J Lüdemann; M Piek; S Sauer; C Adam; G Born; D Alte; E Greiser; U Haertel; H W Hense; J Haerting; S Willich; C Kessler
Journal:  Soz Praventivmed       Date:  2001

5.  Body-mass index and mortality in Korean men and women.

Authors:  Sun Ha Jee; Jae Woong Sull; Jungyong Park; Sang-Yi Lee; Heechoul Ohrr; Eliseo Guallar; Jonathan M Samet
Journal:  N Engl J Med       Date:  2006-08-22       Impact factor: 91.245

6.  The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.

Authors:  Carlos Lorenzo; Mayor Okoloise; Ken Williams; Michael P Stern; Steven M Haffner
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

7.  Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study.

Authors:  David E Laaksonen; Hanna-Maaria Lakka; Leo K Niskanen; George A Kaplan; Jukka T Salonen; Timo A Lakka
Journal:  Am J Epidemiol       Date:  2002-12-01       Impact factor: 4.897

Review 8.  [The metabolic syndrome -- a controversial diagnostic concept].

Authors:  Susanne Moebus; Andreas Stang
Journal:  Herz       Date:  2007-10       Impact factor: 1.443

9.  Assessing the prevalence of the Metabolic Syndrome according to NCEP ATP III in Germany: feasibility and quality aspects of a two step approach in 1550 randomly selected primary health care practices.

Authors:  Susanne Moebus; Jens Ulrich Hanisch; Markus Neuhäuser; Pamela Aidelsburger; Jürgen Wasem; Karl-Heinz Jöckel
Journal:  Ger Med Sci       Date:  2006-10-09

10.  Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS).

Authors:  Susanne Moebus; Jens Ulrich Hanisch; Pamela Aidelsburger; Peter Bramlage; Jürgen Wasem; Karl-Heinz Jöckel
Journal:  Cardiovasc Diabetol       Date:  2007-09-06       Impact factor: 9.951

View more
  20 in total

1.  [Diabetes and rheumatism: is diabetes mellitus also an inflammatory disease?].

Authors:  S Graf; P-M Schumm-Draeger
Journal:  Z Rheumatol       Date:  2011-11       Impact factor: 1.372

2.  An inter-state comparison of cardiovascular risk factors in Germany: towards an explanation of high ischemic heart disease mortality in Saxony-Anhalt.

Authors:  Andreas Stang; Maximilian Stang
Journal:  Dtsch Arztebl Int       Date:  2014-08-04       Impact factor: 5.594

Review 3.  Metabolic syndrome and breast cancer: is there a link?

Authors:  Dagmar Hauner; Hans Hauner
Journal:  Breast Care (Basel)       Date:  2014-04       Impact factor: 2.860

4.  Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population?

Authors:  Kaitlyn Kennard; Meghan E Buckley; Lina M Sizer; Sharon Larson; William B Carter; Thomas G Frazier; Ned Z Carp
Journal:  Breast Cancer Res Treat       Date:  2021-01-03       Impact factor: 4.872

5.  Regional Differences in the Prevalence of Cardiovascular Disease.

Authors:  Christina Dornquast; Lars E Kroll; Hannelore K Neuhauser; Stefan N Willich; Thomas Reinhold; Markus A Busch
Journal:  Dtsch Arztebl Int       Date:  2016-10-21       Impact factor: 5.594

6.  [Medical decision making in symptoms of type 2 diabetes mellitus in general practice].

Authors:  W de Cruppé; O von dem Knesebeck; E Gerstenberger; C Link; L Marceau; J Siegrist; M Geraedts; J McKinlay
Journal:  Dtsch Med Wochenschr       Date:  2011-02-17       Impact factor: 0.628

Review 7.  NASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed?

Authors:  Ali Canbay; Jan-Peter Sowa; Wing-Kin Syn; Jürgen Treckmann
Journal:  Visc Med       Date:  2016-07-29

8.  Overweight, obesity and high waist circumference: regional differences in prevalence in primary medical care.

Authors:  Hans Hauner; Peter Bramlage; Christian Lösch; Karl-Heinz Jöckel; Susanne Moebus; Heribert Schunkert; Jürgen Wasem
Journal:  Dtsch Arztebl Int       Date:  2008-11-28       Impact factor: 5.594

9.  Novel App- and Web-Supported Diabetes Prevention Program to Promote Weight Reduction, Physical Activity, and a Healthier Lifestyle: Observation of the Clinical Application.

Authors:  Johann H Arens; Wolfgang Hauth; Joerg Weissmann
Journal:  J Diabetes Sci Technol       Date:  2018-03-27

10.  [Pulmonary function in elderly subjects with metabolic syndrome and type II diabetes : Data from the Berlin Aging Study II].

Authors:  Nikolaus Buchmann; Kristina Norman; Elisabeth Steinhagen-Thiessen; Ilja Demuth; Rahel Eckardt
Journal:  Z Gerontol Geriatr       Date:  2015-10-27       Impact factor: 1.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.